Jeremy Youde
The coronavirus pandemic has inspired a great deal of scientific research into developing a vaccine for COVID-19. The process is moving much faster than normal, with more than 155 vaccine candidates currently being developed, 23 of which are already in human trials. Vaccines can take years or even decades to develop and distribute, but the Trump administration is pushing to have one ready by early next year.
Developing a vaccine is one thing, but making it available to people is another issue altogether—one that involves thorny questions of ethics, intellectual property rights, global trade and recouping research costs.
No comments:
Post a Comment